Defining Global Benchmarks for Laparoscopic Liver Resections: An International Multicenter Study.


Journal

Annals of surgery
ISSN: 1528-1140
Titre abrégé: Ann Surg
Pays: United States
ID NLM: 0372354

Informations de publication

Date de publication:
01 04 2023
Historique:
pubmed: 16 7 2022
medline: 14 3 2023
entrez: 15 7 2022
Statut: ppublish

Résumé

To establish global benchmark outcomes indicators after laparoscopic liver resections (L-LR). There is limited published data to date on the best achievable outcomes after L-LR. This is a post hoc analysis of a multicenter database of 11,983 patients undergoing L-LR in 45 international centers in 4 continents between 2015 and 2020. Three specific procedures: left lateral sectionectomy (LLS), left hepatectomy (LH), and right hepatectomy (RH) were selected to represent the 3 difficulty levels of L-LR. Fifteen outcome indicators were selected to establish benchmark cutoffs. There were 3519 L-LR (LLS, LH, RH) of which 1258 L-LR (40.6%) cases performed in 34 benchmark expert centers qualified as low-risk benchmark cases. These included 659 LLS (52.4%), 306 LH (24.3%), and 293 RH (23.3%). The benchmark outcomes established for operation time, open conversion rate, blood loss ≥500 mL, blood transfusion rate, postoperative morbidity, major morbidity, and 90-day mortality after LLS, LH, and RH were 209.5, 302, and 426 minutes; 2.1%, 13.4%, and 13.0%; 3.2%, 20%, and 47.1%; 0%, 7.1%, and 10.5%; 11.1%, 20%, and 50%; 0%, 7.1%, and 20%; and 0%, 0%, and 0%, respectively. This study established the first global benchmark outcomes for L-LR in a large-scale international patient cohort. It provides an up-to-date reference regarding the "best achievable" results for L-LR for which centers adopting L-LR can use as a comparison to enable an objective assessment of performance gaps and learning curves.

Sections du résumé

OBJECTIVE
To establish global benchmark outcomes indicators after laparoscopic liver resections (L-LR).
BACKGROUND
There is limited published data to date on the best achievable outcomes after L-LR.
METHODS
This is a post hoc analysis of a multicenter database of 11,983 patients undergoing L-LR in 45 international centers in 4 continents between 2015 and 2020. Three specific procedures: left lateral sectionectomy (LLS), left hepatectomy (LH), and right hepatectomy (RH) were selected to represent the 3 difficulty levels of L-LR. Fifteen outcome indicators were selected to establish benchmark cutoffs.
RESULTS
There were 3519 L-LR (LLS, LH, RH) of which 1258 L-LR (40.6%) cases performed in 34 benchmark expert centers qualified as low-risk benchmark cases. These included 659 LLS (52.4%), 306 LH (24.3%), and 293 RH (23.3%). The benchmark outcomes established for operation time, open conversion rate, blood loss ≥500 mL, blood transfusion rate, postoperative morbidity, major morbidity, and 90-day mortality after LLS, LH, and RH were 209.5, 302, and 426 minutes; 2.1%, 13.4%, and 13.0%; 3.2%, 20%, and 47.1%; 0%, 7.1%, and 10.5%; 11.1%, 20%, and 50%; 0%, 7.1%, and 20%; and 0%, 0%, and 0%, respectively.
CONCLUSIONS
This study established the first global benchmark outcomes for L-LR in a large-scale international patient cohort. It provides an up-to-date reference regarding the "best achievable" results for L-LR for which centers adopting L-LR can use as a comparison to enable an objective assessment of performance gaps and learning curves.

Identifiants

pubmed: 35837974
doi: 10.1097/SLA.0000000000005530
pii: 00000658-202304000-00040
doi:

Types de publication

Multicenter Study Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

e839-e848

Subventions

Organisme : NCI NIH HHS
ID : P30 CA008748
Pays : United States

Investigateurs

Nicholas Syn (N)
Mikel Prieto (M)
Henri Schotte (H)
Celine De Meyere (C)
Felix Krenzien (F)
Moritz Schmelzle (M)
Kit-Fai Lee (KF)
Diana Salimgereeva (D)
Ruslan Alikhanov (R)
Lip-Seng Lee (LS)
Jae Young Jang (JY)
Masayuki Kojima (M)
Jacob Ghotbi (J)
Jaime Arthur Pirola Kruger (JAP)
Victor Lopez-Lopez (V)
Bernardo Dalla Valle (BD)
Margarida Casellas I Robert (M)
Kohei Mishima (K)
Roberto Montalti (R)
Mariano Giglio (M)
Alessandro Mazzotta (A)
Boram Lee (B)
Hao-Ping Wang (HP)
Franco Pascual (F)
Prashant Kadam (P)
Chung-Ngai Tang (CN)
Shian Yu (S)
Francesco Ardito (F)
Simone Vani (S)
Ugo Giustizieri (U)
Davide Citterio (D)
Federico Mocchegiani (F)
Giuseppe Maria Ettorre (GM)
Marco Colasanti (M)
Yoelimar Guzmán (Y)

Informations de copyright

Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.

Déclaration de conflit d'intérêts

B.K.P.G. has received travel grants and honorarium from Johnson and Johnson, Olympus, and Transmedic the local distributor for the Da Vinci Robot. M.V.M. is a consultant for CAVA robotics LLC. J.P. reports a research grant from Intuitive Surgical Deutschland GmbH and personal fees or nonfinancial support from Johnson & Johnson, Medtronic, AFS Medical, Astellas, CHG Meridian, Chiesi, Falk Foundation, La Fource Group, Merck, Neovii, NOGGO, pharma-consult Peterson, and Promedicis. M.S. reports personal fees or other support outside of the submitted work from Merck, Bayer, ERBE, Amgen, Johnson & Johnson, Takeda, Olympus, Medtronic, and Intuitive. A.F. reports receiving speaker fees from Bayer. F.R. reports speaker fees and support outside the submitted work from Integra, Medtronic, Olympus, Corza, Sirtex, and Johnson & Johnson. The remaining authors report no conflicts of interest.

Références

Von Eiff W. International benchmarking and best practice management: in search of health care and hospital excellence. Adv Health Care Manag. 2015;17:223–252.
Staiger RD, Schwandt H, Puhan MA, et al. Improving surgical outcomes through benchmarking. Br J Surg. 2019;106:59–64.
Clavien PA, Puhan MA. Measuring and achieving the best possible outcomes in surgery. Br J Surg. 2017;104:1121–1122.
Porter ME. What is the value of health care? N Engl J Med. 2010;363:2477–2481.
Sanchez-Velazquez P, Muller X, Malleo G, et al. Benchmarks in pancreatic surgery: a novel tool for unbiased outcome comparisons. Ann Surg. 2019;270:211–218.
Muller X, Marcon F, Sapisochin G, et al. Defining benchmarks in liver transplantation: a multicenter outcome analysis determining best achievable results. Ann Surg. 2018;267:419–425.
Gero D, Raptis DA, Vleeschouwers W, et al. Defining global benchmarks in bariatric surgery: a retrospective multicenter analysis of minimally invasive roux-en-y gastric bypass and sleeve gastrectomy. Ann Surg. 2019;270:859–867.
Rossler F, Sapisochin G, Song GW, et al. Defining benchmarks for major liver surgery: a multicenter analysis of 5202 living liver donors. Ann Surg. 2016;264:492–500.
Ciria R, Cherqui D, Geller DA, et al. Comparative short-term benefits of laparoscopic liver resection: 9000 cases and climbing. Ann Surg. 2016;263:761–777.
Goh BK, Lee SY, Teo JY, et al. Changing trends and outcomes associated with the adoption of minimally invasive hepatectomy: a contemporary single-institution experience with 400 consecutive resections. Surg Endosc. 2018;32:4658–4665.
Hobeika C, Fuks D, Cauchy F, et al. Benchmark performance of laparoscopic left lateral sectionectomy and right hepatectomy in expert centers. J Hepatol. 2020;73:1100–1108.
Russolillo N, Aldrighetti L, Cillo U, et al. Risk-adjusted benchmarks in laparoscopic liver surgery in a national cohort. Br J Surg. 2020;107:845–853.
Chua D, Syn N, Koh YX, et al. Learning curves in minimally invasive hepatectomy: systematic review and meta-regression analysis. Br J Surg. 2021;108:351–358.
Goh BK, Prieto M, Syn N, et al. Critical appraisal of the learning curve of minimally invasive hepatectomy: experience with the first 200 cases of a Southeast Asian Early adopted. ANZ J Surg. 2020;90:1092–1098.
Kawaguchi Y, Fuks D, Kokudo N, et al. Difficulty of laparoscopic liver resection: proposal for a new classification. Ann Surg. 2018;267:13–17.
Halls MC, Berardi G, Cipriani F, et al. Development and validation of a difficulty score to predict intraoperative complications during laparoscopic liver resection. Br J Surg. 2018;105:1182–1191.
Wakabayashi G. What has changed after the Morioka consensus conference 2014 on laparoscopic liver resection? Hepatobiliary Surg Nutr. 2016;5:281–2819.
Goh BK, Prieto M, Syn N, et al. Validation and comparison of the Iwate, IMM, Southampton and Hasegawa difficulty scoring systems for primary laparoscopic hepatectomies. HPB. 2021;23:770–776.
Van der poel MJ, Fichteinger RS, Bemelmans M, et al. Implementation and outcome of minor and major minimally invasive liver surgery in The Netherlands. HPB. 2019;21:1734–1743.
Cheung TT, Wang X, Efanov M, et al. Minimally invasive liver resection for huge (≥10 cm) tumors: an international multicenter matched cohort study with regression discontinuity analyses. Hepatobiliary Surg Nutr. 2021;10:587–597.
Troisi RI, Berardi G, Morise Z, et al. Laparoscopic and open liver resection for hepatocellular carcinoma with Child-Pugh B cirrhosis: multicentre propensity score-matched study. Br J Surg. 2021;108:196–204.
Gorgec B, Cacciaguerra AB, Lanari J, et al. Assessment of textbook outcome in laparoscopic and open liver surgery. JAMA Surg. 2021;156:e212064.
Mueller M, Breuer E, Mizuno T, et al. Perihilar cholangiocarcinoma-novel benchmark values for surgical and oncological outcomes from 24 expert centers. Ann Surg. 2021;274:780–788.
Vigano L, Torzilli G, Aldrighetti L, et al. Stratification of major hepatectomies according to their outcome: analysis if 2212 consecutive open resections in patients without cirrhosis. Ann Surg. 2020;272:827–833.
Strasberg SM. Nomenclature of hepatic anatomy and resection: a review of Brisbane 2000 system. J Hepatobiliary Pancreat Surg. 2005;12:351–355.
Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240:205–213.
Ghaferi AA, Birkmeyer JD, Dimick JB. Complications, failure to rescue, and mortality with inpatient surgery in Medicare patients. Ann Surg. 2009;250:1029–1034.
Fretland AA, Dagenborg VJ, Bjornelv GM, et al. Laparoscopic versus open resection for colorectal liver metastases: the OSLO-COMET randomized controlled trial. Ann Surg. 2019;267:199–207.
Syn N, Kabir T, Koh YX, et al. Survival advantage of laparoscopic versus open resection for colorectal liver metastases: a meta-analysis of individual patient data from randomized trials and propensity-score matched studies. Ann Surg. 2020;272:253–265.
Goh BK. Letter regarding “Benchmark performance of laparoscopic left lateral sectionectomy and right hepatectomy in expert centers”. J Hepatol. 2020;73:1576.
Weissman N, Allison J, Kiefe C, et al. Achievable benchmarks of care: the ABCs of benchmarking. J Eval Clin Pract. 1999;5:269–281.
Goh BK, Lee SY, Koh YX, et al. Minimally invasive major hepatectomies: a Southeast Asian single institution contemporary experience with its first 120 consecutive cases. ANZ J Surg. 2020;90:553–557.
Russolillo N, Aldrighetti L, Guglielmi A, et al. Correspondence on “Benchmark performance of laparoscopic left lateral sectionectomy and right hepatectomy in expert centers. J Hepatol, 2021;74:985–986.
Tsilimigras DI, Sahara K, Moris D, et al. Assessing textbook outcomes following liver surgery for primary liver cancer over a 12-year time period at major hepatobiliary centers. Ann Surg Oncol. 2020;27:3318–3327.
Goh BK, Wang Z, Koh YX, et al. Evolution and trends in the adoption of laparoscopic liver resection in Singapore: analysis of 300 cases based on a single surgeon experience. Ann Acad Med Singapore. 2021;50:742–750.
Aldrighetti L, Cipriani F, Fiorentini G, et al. A stepwise learning curve to define the standard for technical improvement in laparoscopic liver resections: complexity-based analysis in 1032 procedures. Updates Surg. 2019;71:273–283.
Aghayan DL, Kazaryan AM, Fretland AA, et al. Evolution of laparoscopic liver surgery: 20-year experience of a Norwegian high-volume referral center. Surg Endosc. 2022;36:2818–2826.

Auteurs

Brian K P Goh (BKP)

Department of Hepatopancreatobiliary and Transplant Surgery,, Singapore General Hospital, National Cancer Centre Singapore and Duke-National University of Singapore Medical School, Singapore, Singapore.

Ho-Seong Han (HS)

Department of Surgery, Seoul National University Hospital Bundang, Seoul National University College of Medicine, Seoul, Korea.

Kuo-Hsin Chen (KH)

Division of General Surgery, Department of Surgery, Far-Eastern Memorial Hospital, New Taipei City, Taiwan.

Darren W Chua (DW)

Department of Hepatopancreatobiliary and Transplant Surgery,, Singapore General Hospital, National Cancer Centre Singapore and Duke-National University of Singapore Medical School, Singapore, Singapore.

Chung-Yip Chan (CY)

Department of Hepatopancreatobiliary and Transplant Surgery,, Singapore General Hospital, National Cancer Centre Singapore and Duke-National University of Singapore Medical School, Singapore, Singapore.

Federica Cipriani (F)

Hepatobiliary Surgery Division, IRCCS San Raffaele Hospital, Milan, Italy.

Davit L Aghayan (DL)

The Intervention Centre and Department of HPB Surgery, Oslo University Hospital, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.

Asmund A Fretland (AA)

The Intervention Centre and Department of HPB Surgery, Oslo University Hospital, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.

Jasper Sijberden (J)

Department of Surgery, Poliambulanza Foundation Hospital, Brescia,Italy.

Mizelle D'Silva (M)

Department of Surgery, Seoul National University Hospital Bundang, Seoul National University College of Medicine, Seoul, Korea.

Tiing Foong Siow (TF)

Division of General Surgery, Department of Surgery, Far-Eastern Memorial Hospital, New Taipei City, Taiwan.

Yutaro Kato (Y)

Department of Surgery, Fujita Health University School of Medicine, Aichi, Japan.

Chetana Lim (C)

Department of Digestive, HBP and Liver Transplantation, Pitie Salpetriere Hospital, APHP Paris, Sorbonne Universite, Paris, France.

Phan Phuoc Nghia (PP)

HPB Surgery Department, University Medical Center, Ho Chi Minh City, Vietnam.

Paulo Herman (P)

Liver Surgery Unit, Department of Gastroenterology, University of Sao Paulo School of Medicine, Sao Paulo, Brazil.

Marco V Marino (MV)

General Surgery Department, Azienda Ospedaliera Ospedali Riuniti Villa Sofia-Cervello, Palermo, Italy.
Oncologic Surgery Department, P. Giaccone University Hospital, Palermo, Italy.

Vincenzo Mazzaferro (V)

HPB Surgery and Liver Transplantation, Fondazione IRCCS Istituto Nazionale Tumori di Milano and University of Milan, Milan, Italy.

Adrian K H Chiow (AKH)

Hepatopancreatobiliary Unit, Department of Surgery, Changi General Hospital, Singapore.

Iswanto Sucandy (I)

AdventHealth Tampa, Digestive Health Institute, Tampa, FL.

Arpad Ivanecz (A)

Department of Abdominal and General Surgery, University Medical Center Maribor, Maribor, Slovenia.

Sung Hoon Choi (SH)

Department of General Surgery, CHA Bundang Medical Center, CHA University School of Medicine, Seongnam, Korea.

Jae Hoon Lee (JH)

Department of Surgery, Division of Hepato-Biliary and Pancreatic Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.

Mikel Gastaca (M)

Hepatobiliary Surgery and Liver Transplantation Unit, Biocruces Bizkaia Health Research Institute, Cruces University Hospital, University of the Basque Country, Bilbao, Spain.

Marco Vivarelli (M)

HPB Surgery and Transplantation Unit, United Hospital of Ancona, Department of Sperimental and Clinical Medicine Polytechnic University of Marche, Ancona, Italy.

Felice Giuliante (F)

Hepatobiliary Surgery Unit, Fondazione Policlinico Universitario A. Gemelli, IRCCS, Catholic University of the Sacred Heart, Rome, Italy.

Andrea Ruzzenente (A)

Department of Surgery, Dentistry, Gynecology, and Pediatrics, University of Verona, GB Rossi Hospital, Verona, Italy.

Chee-Chien Yong (CC)

Department of Surgery, Chang Gung Memorial Hospital, Kaohsiung, Taiwan.

Mengqui Yin (M)

Department of Hepatobiliary Surgery, Affiliated Jinhua Hospital, Zhejiang University School of Medicine, Jinhua, China.

Zewei Chen (Z)

Department of Hepatobiliary Surgery, Affiliated Jinhua Hospital, Zhejiang University School of Medicine, Jinhua, China.

Constantino Fondevila (C)

General and Digestive Surgery, Hospital Universitario La Paz, IdiPAZ, Madrid, Spain.
General and Digestive Surgery, Hospital Clinic, IDIBAPS, CIBERehd, University of Barcelona, Barcelona, Spain.

Mikhail Efanov (M)

Department of Hepato-Pancreato-Biliary Surgery, Moscow Clinical Scientific Center, Moscow, Russia.

Fernando Rotellar (F)

HPB and Liver Transplant Unit, Department of General Surgery, University Clinic of Navarra, University of Navarra, Pamplona, Spain.
Institute of Health Research of Navarra (IdisNA), Pamplona, Spain.

Gi-Hong Choi (GH)

Division of Hepatopancreatobiliary Surgery, Department of Surgery, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.

Ricardo R Campos (RR)

Department of General, Visceral and Transplantation Surgery, Clinic and University Hospital Virgen de la Arrixaca, IMIB-ARRIXACA, El Palmar, Murcia, Spain.

Xiaoying Wang (X)

Department of Liver Surgery and Transplantation, Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, China.

Robert P Sutcliffe (RP)

Department of Hepatopancreatobiliary and Liver Transplant Surgery, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.

Johann Pratschke (J)

Department of Surgery, Campus Charité Mitte and Campus Virchow-Klinikum, Charité-Universitätsmedizin, Corporate Member of Freie Universität Berlin, and Berlin Institute of Health, Berlin, Germany.

Eric Lai (E)

Department of Surgery, Pamela Youde Nethersole Eastern Hospital, Hong Kong SAR, China.

Charing C Chong (CC)

Department of Surgery, Prince of Wales Hospital, The Chinese University of Hong Kong, New Territories, Hong Kong SAR, China.

Mathieu D'Hondt (M)

Department of Digestive and Hepatobiliary/Pancreatic Surgery, Groeninge Hospital, Kortrijk, Belgium.

Kazuteru Monden (K)

Department of Surgery, Fukuyama City Hospital, Hiroshima, Japan.

Santiago Lopez-Ben (S)

Hepatobiliary and Pancreatic Surgery Unit, Department of Surgery, Dr. Josep Trueta Hospital, IdIBGi, Girona, Spain.

Fabricio F Coelho (FF)

Liver Surgery Unit, Department of Gastroenterology, University of Sao Paulo School of Medicine, Sao Paulo, Brazil.

Thomas Peter Kingham (TP)

Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY.

Rong Liu (R)

Faculty of Hepatopancreatobiliary Surgery, The First Medical Center of Chinese People's Liberation Army (PLA) General Hospital, Beijing, China.

Tran Cong Duy Long (TCD)

Department of Hepatopancreatobiliary Surgery, University Medical Center, University of Medicine and Pharmacy, Ho Chi Minh City, Vietnam.

Alessandro Ferrero (A)

Department of General and Oncological Surgery, Mauriziano Hospital, Turin, Italy.

Giovanni B Levi Sandri (GBL)

Division of General Surgery and Liver Transplantation, S. Camillo Hospital, Rome, Italy.

Mansour Saleh (M)

Department of Hepatobiliary Surgery, Assistance Publique Hopitaux de Paris, Centre Hepato-Biliaire, Paul-Brousse Hospital, Villejuif, France.

Daniel Cherqui (D)

Department of Hepatobiliary Surgery, Assistance Publique Hopitaux de Paris, Centre Hepato-Biliaire, Paul-Brousse Hospital, Villejuif, France.

Olivier Scatton (O)

Department of Digestive, HBP and Liver Transplantation, Pitie Salpetriere Hospital, APHP Paris, Sorbonne Universite, Paris, France.

Olivier Soubrane (O)

Department of Digestive, Oncologic, and Metabolic Surgery, Institute Mutualiste Montsouris, Universite Paris Descartes, Paris, France.

Go Wakabayashi (G)

Center for Advanced Treatment of Hepatobiliary and Pancreatic Diseases, Ageo Central General Hospital, Saitama, Japan.

Roberto I Troisi (RI)

Division of HPB, Department of Clinical Medicine and Surgery, Minimally Invasive and Robotic Surgery, Federico II University Hospital Naples, Naples, Italy.

Tan-To Cheung (TT)

Department of Surgery, Queen Mary Hospital, The University of Hong Kong, Hong Kong SAR, China.

Atsushi Sugioka (A)

Department of Surgery, Fujita Health University School of Medicine, Aichi, Japan.

Mohammad Abu Hilal (MA)

Department of Surgery, Poliambulanza Foundation Hospital, Brescia,Italy.
Department of Surgery, University Hospital Southampton, Southampton, UK.

David Fuks (D)

Department of Digestive, Oncologic, and Metabolic Surgery, Institute Mutualiste Montsouris, Universite Paris Descartes, Paris, France.

Bjørn Edwin (B)

The Intervention Centre and Department of HPB Surgery, Oslo University Hospital, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.

Luca Aldrighetti (L)

Hepatobiliary Surgery Division, IRCCS San Raffaele Hospital, Milan, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH